|
Last
updated February 4, 2005
Saturday, MAY 14
8:00am–11:00am
4153—Developmental
Care (DC) in the Newborn Nursery—An Interactive Workshop
PAS Educational Workshop
Leader:
Juzer M. Tyebkhan, Edmonton, AB, Canada; Co-leader:
Leonora Hendson
Understand what developmental care (DC) really is,
why it is beneficial for preterm infants and how to
practically implement it in your nursery. This is an
interactive workshop that will answer the frequently asked
question, "Exactly what should we do DIFFERENTLY if
we use DC to care for preterm infants?" The workshop
will include a quiz (informal and entertaining), video
demonstrations of DC at the bedside compared with
traditional (non-developmental) care, a slide show/video
showing how a routine NICU procedure (extubation) can be
made family-centered, behaviourally guided and
developmentally friendly. Participants will be actively
involved and will take home at least three practical
points that will help them implement DC in their
nurseries.
Objectives:
-
Participants will know the scientific basis for
developmental care and the evidence supporting its
use.
-
Participants will take back at least three practical
points that will allow them to implement developmental
care in their nurseries.
Method of Instruction: (1) Introduction; (2) quiz
(informal, interactive and entertaining): the scientific
background, and current evidence for DC (Powerpoint
presentation); (3) "hands-on" practice with
behavioural observation, as a framework for implementing
DC; (4) video demonstrations of DC at tbe bedside compared
with traditional (non-developmental) care, and of infant
behavioural responses; (5) Slide show/video, "Family
centered, behaviourally guided and developmentally
friendly extubation": How to make the change from
traditional, procedure-based care to developmental,
family-centered care using a practical example—the
extubation of a preterm infant; (6) Participant input: How
can we really become "Family Centered" in the
NICU?; (7) Roundtable discussion: Overcoming the obstacles
to implementing DC in the nursery; (8) Summing up.
Handouts, summarizing the workshop, with reference list
will be provided. A "Developmental Survival
Card" will be given to all participants.
Target Audience: Trainee, junior faculty, mid-level
faculty, all disciplines that work in neonatal nurseries
11:45am–2:45pm
4503—Neonatal
Follow-Up: A Global Perspective
PAS Mini Course
Chair:
Maureen Hack, Case Western Reserve University, Cleveland,
OH
The increase in survival of extremely immature
infants, together with the institution of randomized
clinical trials to assess the efficacy and safety of the
many technologic and pharmacologic advances in perinatal
care, has led to a renewed interest in current outcomes
and the methodologic issues related to high-risk
follow-up. Questions include the practicality of actual
assessment of children versus the reliability of parental
reports and age of follow-up. Traditional measures of
outcome have included mainly cognitive and neurosensory
function, but there is increasing interest in the overall
functioning of the child, as well as other measures of
health including health status and quality of life. This
session will review epidemiologic principles and state of
the art measures of cognitive and neuropsychologic
assessment, neurologic impairment, including cerebral
palsy, health status, growth and quality of life. The
presentations will be illustrated with examples of recent
outcome studies. Audience participation will be
encouraged.
Target Audience: Scientists and clinicians involved
with clinical care and research pertaining to the results
of neonatal intensive care.
Historical Overview and Introduction
Maureen
Hack, Case Western Reserve University, Cleveland, OH
Epidemiology Principles in Designing, Executing and
Analyzing Newborn Follow-Up Studies
Nigel
Paneth, Michigan State University College of Human
Medicine, East Lansing, MI
Cognitive and Neurophysiologic Outcomes
Glen
Aylward, Southern Illinois University School of Medicine,
Springfield, IL
Cerebral Palsy and Other Neurologic Outcomes
Betty
R. Vohr, Women and Infant's Hospital, Providence, RI
Health Status and Growth
Maureen
Hack, Case Western Reserve University, Cleveland, OH
Issues in Measuring Quality of Life in Children
Saroj
Saigal, McMaster University, Hamilton, Ontario, Canada
Discussion
1:00pm–3:00pm
4650—ADHD:
Issues In Management
PAS Original Science Abstracts -
Platform Session.
3:15pm–5:15pm
4800—Behavior
Problems, Brain Maturation and the Pediatrician
PAS/SAM Topic Symposium
Chair:
Kathleen A. Pajer, Children's Hospital, Columbus, OH
This symposium will summarize research on behavior
problems in the pediatric population, presented in the
context of new research on brain maturation during
childhood and adolescence. Clinical implications of this
synthetic approach will be discussed. The first
presentation will give an overview of brain maturation and
neural plasticity, focusing on the mechanisms of postnatal
development. We will then review abnormalities in brain
maturation that may underlie emotional and behavioral
dysregulation, constructs strongly correlated with
behavior problems in children and adolescents. Next, we
will present data on how premature adrenarche and the
developing brain may be associated with childhood behavior
problems. The final presentation will discuss adolescent
brain maturation, puberty and behavior problems, with a
focus on hypothalamic pituitary adrenal axis function. Our
discussant will talk about the integration of the two
bodies of work presented and its application to clinical
problems seen by the pediatrician. Our session will
conclude with an opportunity for the audience to ask
questions of the speakers.
Target Audience: Clinical researchers in behavioral
pediatrics and practicing pediatricians.
Behavior Problems, Brain Maturation and the
Pediatrician
Kathleen
A. Pajer, Children's Hospital, Columbus, OH
Brain Development and Neural Plasticity
Charles
A. Nelson, University of Minnesota, Minneapolis, MN
Dysregulation and the Developing Brain
Kathleen
A. Pajer, Children's Hospital, Columbus, OH
Mood and Behavior Problems in Early School-Age
Children: Relationships with Early Puberty and the Adrenal
Axis
Lorah
D. Dorn, Cincinnati Children's Hospital Medical Center,
Cincinnati, OH
Circadian Variations in Gonadal and Adrenal Hormones
and Behavior Problems in Young Adolescents
Elizabeth
J. Susman, The Pennsylvania State University, University
Park, PA
Discussant
Ronald
Dahl, University of Pittsburgh, Pittsburgh, PA
Questions and Discussion with Panel
Sponsored jointly by the Society for
Adolescent Medicine and the Pediatric Academic Societies
Supported in part by an unrestricted
educational grant from Columbus Children's Hospital
Sunday, MAY 15
8:00am–11:00am
5200—ADHD
and Other Disruptive Behaviors in Preschool Children:
Challenges in Diagnosis and Treatment
PAS Mini Course
Chair:
Martin T. Stein, University of California San Diego, San
Diego, CA
Pediatricians typically think about ADHD as a
neurobehavioral condition in school-age children and
adolescents. In preschool children, evidenced-based
studies on diagnosis and treatment of ADHD are limited. In
young children, it is especially difficult to distinguish
hyperactivity, impulsive behaviors and inattention from
developmentally normal behavior in this age group. The
session will begin with a discussion about a
developmental–biopsychosocial model for early
identification and treatment of attentional and disruptive
disorders in young children. Recent studies designed to
define an evidenced-based structure for the diagnosis and
treatment of ADHD in young children will be reviewed.
Current knowledge about the effectiveness of behavior
management, parent training and psychopharmacological
treatments in preschool children with ADHD will be
emphasized. The symposium will target the clinical
challenges of working with preschool children who present
with ADHD-like behaviors in pediatric practice.
Target Audience: Clinicians who see preschool
children and teachers of pediatric residents and medical
students; those who do research in developmental and
behavioral pediatrics and pediatric neurology; clinicians
who want to find direction in evaluating and managing
hyperactive, disruptive and impulsive preschool children;
and to clinicians and those who study disruptive behaviors
in preschool children.
ADHD in Preschool Children: Challenges in Definition,
Diagnosis and Treatment
Martin
T. Stein, University of California San Diego, San Diego,
CA
Developmental–Biopsychosocial Model for Early
Identification and Comprehensive Treatment of Attentional
and Disruptive Disorders in Young Children
Stanley
I. Greenspan, George Washington University School of
Medicine, Washington, DC
Diagnostic Strategies for ADHD in Preschool Children
Helen
Link Egger, Duke University Medical Center, Durham, NC
Treatment of Disruptive Behaviors in Preschool
Children
Chris
K. Varley, University of Washington Medical Center,
Children's Hospital and Regional Medical Center, Seattle,
WA
The Preschool ADHD Treatment Study (PATS Study)
Larry
L. Greenhill, New York State Psychiatric Institute, New
York, NY
Managing Disruptive Preschool Children with ADHD in a
Pediatric Office
Suzanne
Dixon, University of Washington, University of California
San Diego, Emeritus
Discussion
8:00am–11:00am
5232—Design
and Analysis of Childhood Cohort Studies
PAS Educational Workshop
Leader:
Cynthia Minkovitz, Baltimore, MD; Co-leaders: Jennifer
Hawes-Dawson, Kamila Mistry, Amy Rathbun, Mark Schuster,
Jerry West
Childhood longitudinal cohort studies provide
opportunities to examine environmental influences on
children's health over time. They also inform
understanding of developmental trajectories and design of
sound policies and programs.
This workshop introduces three prospective cohort
studies with public use data. The Healthy Steps for Young
Children evaluation follows 5,565 families whose young
children received enhanced developmental services. The
Early Childhood Longitudinal Studies follows 10,600
newborns and 22,000 kindergarteners to study development,
health, child care and education. Healthy Passages follows
5,250 10-year olds and describes evolving adolescent
behaviors.
Participants will review methodological
considerations related to sampling design, variable
specification, data collection timing and cohort
maintenance. Using interactive breakout groups,
participants will propose strategies and challenges for
using cohort studies to address new research questions.
Objectives:
-
Knowledge of three childhood cohort studies and their
public use data sets.
-
Skills related to strategic issues with cohort
studies (e.g., sampling, variable specification,
tracking, cohort maintenance).
Method of Instruction: (1) Interactive discussion of
three childhood cohort studies with question-and-answer
period incorporated, (2) facilitated breakout groups to
apply principles of cohort design to address new research
questions
Target Audience: Trainee, junior faculty.
2:00pm–4:00pm
5535—Neonatal
Epidemiology and Follow-up
PAS Original Science Abstracts -
Platform Session
2:00pm–5:00pm
5561—Pediatric
Neuropharmacology—Current Controversies
PAS Mini Course
Chair:
Faye Silverstein, University of Michigan, Ann Arbor, MI
This mini course will highlight issues of interest to
many pediatricians. Neuroactive drugs are used to treat a
wide range of neurological and behavioral disorders in
children and adolescents. Often, these drugs have not been
systematically evaluated in this age group, and the issue
of “off-label” use of neuroactive drugs has recently
received considerable national attention.
We have recruited five experts in pediatric
therapeutics for this mini course. Four will discuss
treatment issues, and the fifth will discuss ethical
issues that must be considered in pediatric drug testing.
Graham Emslie will discuss the safety and efficacy of
selective serotonin release inhibitors (SSRIs) in children
and adolescents with depression and related disorders. The
controversies regarding the use of these agents in the
pediatric age group have raised important questions for
all pediatricians. He will also highlight important
questions for future research to improve clinical outcomes
of children with psychological disorders.
James McCracken will provide his perspective on the
use of second generation antipsychotics in children and
adolescents. These drugs are widely used to treat a broad
range of behavioral disorders. He will review current
information about the efficacy and tolerability of these
drugs and suggest guidelines for clinical monitoring.
Carter Snead will provide his perspective on the
roles of the new generation of anti-convulsant drugs
(introduced over the past 10 years) in the treatment of
childhood epilepsy. He will discuss some of the drugs that
have already gained widespread usage in children and
discuss their potential risks and benefits.
Judith Owens will discuss current approaches to drug
therapy of pediatric sleep disorders. As new drug
therapies are introduced, both to induce sleep and to
sustain wakefulness, it is likely that their use will
extend to children and adolescents. The diagnosis of sleep
disorders is rapidly increasing in children, and Dr. Owens
will discuss major diagnostic and therapeutic issues.
Joel Frader will discuss ethical issues in pediatric
drug testing. His topics will include: who should give
“consent” for study participation, the circumstances
permitting placebo controls, implications of FDA and/or
NIH incentives/mandates for pediatric testing, conflicts
between care giving and researcher roles, obligations to
provide study results to participants and special
considerations for phase I testing.
Target Audience: Broad range of clinicians who treat
children with neurological and psychological disorders.
Introduction
Faye
S. Silverstein, University of Michigan, Ann Arbor, MI
SSRIs in Pediatrics: What Do We Really Know?
Graham
Emslie, University of Texas–Southwestern Medical Center,
Dallas, TX
Promises and Pitfalls of Newer Antipsychotics in
Children and Adolescents
James
McCracken, UCLA Neuropsychiatric Institute, Los Angeles,
CA
New Anticonvulsants—Roles in Treatment of Childhood
Epilepsy
O.
Carter Snead, The Hospital for Sick Children, University
of Toronto, Toronto, Canada
Drug Therapy of Pediatric Sleep Disorders
Judith
A. Owens, Brown University, Providence, RI
Pediatric Drug Testing: Ethical Considerations
Joel
E. Frader, Children's Memorial Hospital, Chicago, IL
Discussion
Sunday, MAY 15
2:00pm–5:00pm
5586—Developmental–Behavioral
Pediatrics
APA Special Interest Group
Chair:
Daniel Lee Coury, dcoury@chi.osu.edu
For several years there has been an effort nationally
to upgrade the scope and orientation of such visits. The
Developmental–Behavioral Pediatrics SIG will continue
along this theme next year in Washington, DC, with a
program coordinated by Lane Tanner, M.D. and Marty Stein,
M.D. on Rethinking Child Health Supervision. As they point
out, well child care is a core service of pediatrics, but
existing recommendations for its content and timing are
outdated. The schedule of preventive care has been driven
by concerns about preventing infectious disease and
ensuring adequate nutrition. Yet, today, concerns of
children's development and behavior are foremost in the
minds of parents. Because the long-term healthy
development of children remains the primary goal of
parents, clinicians and society, they are interested in
promoting a process of rethinking both the timing and
content of child health supervision. The goal of this
rethinking would be to ensure that preventive pediatric
care in the future will be optimally responsive to the
developmental needs and challenges faced by children and
families. They will introduce the rationale for such a
revision and will facilitate participant discussion and
ideas regarding the priorities and potential within a more
developmentally oriented system of child health
supervision
6:15pm–9:00pm
5880A—Society
for Developmental Pediatrics
Club
Research into Neurodevelopmental
Disabilities: Past, Present and Future
Update on Neurodevelopmental Disabilities Training
Bruce
K. Shapiro
Update on the Relationship of the SDP and the Child
Neurology Society
Peter
A. Blasco, Associate Professor of Pediatrics, Oregon
Health & Science University
Research into Neurodevelopmental Disabilities: Past,
Present and Future
Mark
L. Batshaw
Contact:
Peter Blasco, M.D.
Lend Training Program and CDRC, Portland, OR
Phone: 503-494-2756
Email: blascop@ohsu.edu
Monday, MAY 16
8:00am–10:00am
6100—Outcomes
After Congenital Heart Surgery: Moving Beyond Mortality
PAS Topic Symposium
Chair:
Kathy Jenkins, Children's Hospital Boston, Boston, MA
This topic symposium is directed toward educating
interested members about the state of the art in health
outcomes research for pediatric patients with cardiac
disease. The discussion will range from mortality and cost
associated with cardiac surgery to outcomes in the
developmental and quality-of-life domains.
Target Audience: Physicians, epidemiologists and
trainees with interest in pediatric cardiology, health
outcomes research, health economics and developmental
outcomes in children.
Congenital Heart Disease: Moving Beyond Mortality
Kathy
J. Jenkins, Children's Hospital Boston, Boston, MA
Neurodevelopmental Outcomes in Children with
Congenital Heart Disease: Where Are We and Where Are We
Going?
Caren
Goldberg, University of Michigan, C.S. Mott Children's
Hospital, Ann Arbor, MI
Improving Physical Functioning in Congenital Heart
Disease
Ruey
Chang, David Geffen School of Medicine, Los Angeles, CA
Cardiac Rehabilitation for Congenital Heart Disease
Jonathan
Rhodes, Children's Hospital Boston, Boston, MA
Resource Use of Congenital Heart Disease
Jean
Connor, Children's Hospital Boston, Boston, MA
Discussion
8:00am–10:00am
6132—Clinical
Trials in Perinatal and Neonatal Medicine I
PAS Original Science Abstracts -
Platform Session
8:00am–10:00am
6139—Neonatal
Outcomes: Impact of Health Services Utilization and
Socioeconomics
PAS Original Science Abstracts -
Platform Session
8:00am–10:00am
6141—Neurodevelopmental
Disabilities
PAS Original Science Abstracts -
Poster Symposium
10:15am–12:15pm
6351—Behavioral–Developmental
Pediatrics
PAS Original Science Abstracts -
Platform Session
10:15am–12:15pm
6356—Medical
Education: Innovations in Medical Education
PAS Original Science Abstracts -
Platform Session
10:15am–12:15pm
6358—Underserved
Populations II
PAS Original Science Abstracts -
Platform Session
3:00pm–5:00pm
6731—Management
and Outcomes of Very Low Birth Weight Infants
PAS Original Science Abstracts -
Platform Session
Tuesday, MAY 17
8:00am–10:00am
7152—Clinical
Trials in Perinatal and Neonatal Medicine II
PAS Original Science Abstracts -
Platform Session
8:45am–11:45am
7211—Treating
Childhood Obesity in Primary Care
PAS Educational Workshop
Leader:
Ellen R. Wald, Pittsburgh, PA; Co-leader: Linda J. Ewing
To overcome barriers to the identification and
treatment of obesity in children, we have developed a
program directed at primary care providers and families of
overweight 8–12 year olds. This program, successful in a
research setting, was adapted and applied in the primary
care setting. The program consists of a module for primary
care providers and a module to train health educators from
among the office staff to deliver a behaviorally based
group intervention focusing on a modification of dietary
and physical activity habits. This interactive workshop
will demonstrate all the components of the program through
role play.
Objectives:
-
Participants will gain knowledge about obesity and
behaviorally based interventions.
-
Participants will acquire skills in reflective
listening.
Method of Instruction: Brief didactic session
followed by interactive demonstrations of provider and
parent modules.
Target Audience: Trainee, junior faculty, mid-level
faculty.
10:15am–11:45am
7302—Influences
on the Health and Development of Minority Children: An
Integrative, Ecological Approach
PAS State of the Art Plenary
Chair:
Lee M. Pachter, Saint Francis Hospital and Medical Center
and University of Connecticut School of Medicine,
Hartford, CT
There is growing recognition that developmental
outcomes in minority children are influenced by factors
that are either unique to minority children or that have
differing effects among minority and nonminority children.
This topic symposium will consist of presentations on the
effects of different contextual variables on minority
child behavioral and developmental competencies. A
conceptual model describing the inter-relationship among
these factors and minority child developmental
competencies will be presented, followed by research that
explores the differing effects of individual, family and
community level contexts on the health and development of
minority children.
Target Audience: Researchers, clinicians and
educators involved with primary care and
behavioral/developmental services to minority families.
Introduction
Lee
M. Pachter, Saint Francis Hospital and Medical Center and
University of Connecticut School of Medicine, Hartford, CT
Minority Child Development: An Integrative Model
Cynthia
García Coll, Brown University, Providence, RI
The Six Primary Tasks of Parenting
Robert
H. Bradley, University of Arkansas at Little Rock, Little
Rock, AR
Ethnic Gaps in Early Health and Development: Causes,
Consequences and Prevention
Jeanne
Brooks-Gunn, Columbia University, New York, NY
Closing Remarks
Lee
M. Pachter, Saint Francis Hospital and Medical Center and
University of Connecticut School of Medicine, Hartford, CT
12:00pm–1:30pm
Poster
Session IV
PAS Original Science Abstracts -
Poster Session
Behavioral and Developmental Pediatrics:
7461—Behavioral Health, Promotion and Intervention
|
